Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy

Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy

Item
http://www.wikidata.org/entity/Q34631627
Impacts of MR spectroscopic imaging on glioma patient management.EDI3 links choline metabolism to integrin expression, cell adhesion and spreadingMyoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.Current Clinical Brain Tumor ImagingEmerging biomarkers in glioblastomaBevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas.In vivo Metabolic Profiles as Determined by (31)P and short TE (1)H MR-Spectroscopy : No Difference Between Patients with IDH Wildtype and IDH Mutant Gliomas.Intracellular pH measured by 31 P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapy.Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients.[Towards more precision in the therapy of brain tumors. Possibilities and limits of MRI].Glycerophosphatidylcholine PC(36:1) absence and 3'-phosphoadenylate (pAp) accumulation are hallmarks of the human glioma metabolome
P2860

Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy

Item
http://www.wikidata.org/entity/Q34631627
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@ast
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@en
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@nl
type
label
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@ast
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@en
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@nl
prefLabel
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@ast
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@en
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Phospholipid metabolites in re ...... d under antiangiogenic therapy
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0056439
P407
P433
P478
P50
P577
P5875
P698
P932